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Aim: The effects of local applied NO-active compounds on glutamate (GLU)-evoked responses were
investigated in globus pallidus (GP) neurons.
Main methods: Extracellularly recorded single units from anesthetized rats were treated with GLU before and
during the microiontophoretic application of S-nitrosoglutathione (SNOG), a NO donor, and Nω-nitro-L-
arginine methyl ester (L-NAME), a NOS inhibitor.
Key ﬁndings:Most GP cells were excited by SNOG whereas administration of L-NAME induced decrease of GP
neurons activity. Nearly all neurons responding to SNOG and/or L-NAME showed signiﬁcant modulation of
their excitatory responses to the administration of iontophoretic GLU. In these cells, the changes induced by
NO-active drugs in themagnitude of GLU-evoked responses were used as indicators of NOmodulation. In fact,
when a NO-active drug was co-iontophoresed with GLU, signiﬁcant changes in GLU-induced responses were
observed: generally, increased magnitudes of GLU-evoked responses were observed during SNOG ejection,
whereas the administration of L-NAME decreased responses to GLU.
Signiﬁcance: The results suggest that the NO-active drugs modulate the response of GP neurons to
glutamatergic transmission. Nitrergic modulation of glutamatergic transmission could play an important role
in the control of GP bioelectric activity, considered a fundamental key in the BG function.
© 2011 Elsevier Inc. All rights reserved.Introduction
The globus pallidus (GP) of rodents, homologous to the external GP
of primates, plays a critical role in basal ganglia (BG) function, by virtue
of rich reciprocal connections with the other nuclei belonging to the BG
system. The activity of GP neurons is controlled by three major sources:
striatal GABAergic inhibitory inputs, subthalamic glutamatergic excit-
atory inputs, and BG intrinsic collateral inhibitory inputs (Hazrati and
Parent, 1992; Parent et al., 2000; Nambu et al., 2000). Furthermore, GP
also receives external excitatoryprojections, such as cortical inputs from
frontal cortex, thalamo-pallidal ﬁbers arising from neurons located in
the parafascicular nucleus, serotoninergic innervation from the dorsal
raphe nucleus, and cholinergic/GABAergic/glutamatergic projection
from the pedunculopontine tegmentum (Parent and Hazrati, 1995;
Naito and Kita, 1994; Mouroux et al., 1997; Yasukawa et al., 2004; Chen
et al., 2008). In turn, GABAergic GP neurons project to the striatum, the
subthalamic nucleus (STN), both the substantia nigra pars compacta
(SNpc) and pars reticulata (SNpr) and the entopeduncular nucleus,
homologous to the internal segment of the GP in primates (Sato et al.,
2000; Lee and Tepper, 2009).erimentale Sezionedi Fisiologia
o Tukory, 129 I-90134 Palermo,
.
l rights reserved.Glutamatergic inputs have been demonstrated to greatly modulate
the spontaneous (Bevan et al., 2002) GP activity through the
activation of both AMPA/kainate and NMDA receptors (Kita et al.,
2004), aside with metabotropic glutamate receptors (mGluRs) (Conn
et al., 2005; Rouse et al., 2000). The glutamatergic drive to the GP
neuronal activity has been shown to be differently modulated by
classical neurotransmitters and neuromodulators (Chen et al., 2006;
Hernandez et al., 2007).
In this regard, our previous studies have shown marked effects
induced on the activity of GP neurons by drugs modulating the nitric
oxide (NO) neurotransmitter system (Sardo et al., 2002a, 2003). Such
gaseous messenger is a modulator of neurotransmission (Prast and
Philippu, 2001) and the neuronal isoform of NO-synthase (nNOS), the
NO-producing enzyme, is widely distributed in the rat brain (De Vente
et al., 1998), including GP (Rodrigo et al., 1994). In a previous study
we observed that the systemic administration of 7-nitro-indazole, a
preferential inhibitor of nNOS, induced a decrease of the ﬁring rate of
responsive GP neurons; similarly, the microiontophoretic application
of Nω-nitro-L-arginine methyl ester (L-NAME), a nonspeciﬁc inhibitor
of nNOS, induced a decrease in the ﬁring rate of most recorded
neurons; furthermore, the local administration of 3-morpholinosyd-
nonimin-hydrocloride (SIN-1), a NO donor, induced an increase of the
ﬁring activity of GP neurons (Sardo et al., 2002a). Moreover, in a
recent in vivo study we highlighted a NO-induced modulation of
GABAergic and glutamatergic neurotransmission in the STN (Sardo et
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glutamatergic and NO systems takes place in the GP, in this study we
compared the effects of the iontophoretic administration of glutamate
(GLU) before and during the co-administration of either L-NAME or S-
nitroso-glutathione (SNOG, a NO donor) in extracellullarly recorded
GP neurons.
Material and methods
Animals and surgery
The study was performed on 36 male Wistar rats (Morini, Italy)
weighing 220–280 g on the day of the experiment, anesthetized with
urethane (Sigma Chemical Co., St. Louis, MO, U.S.A.) at the dose of
1.2 g/kg i.p. Animals were positioned in a stereotaxic apparatus
(David Kopf Instruments, Tujunga, CA, U.S.A.). Body temperature was
maintained at 37–38 °C using a heating pad. Heart rate and pupillary
diameter were monitored throughout all experimental sessions. A
3 mm burr hole was drilled in the skull (7.7 mm anterior to the
interaural line, 3.1 mm lateral to the midline). In each experimental
step, all efforts were made to minimize the number of animals used
and their suffering. All experiments were performed in strict
accordance with the Italian laws on animal experimentation (D.L.
116/1992) andwith the National Institute of Health Guide for the Care
and Use of Laboratory Animals (1986).
Electrophysiological recordings
Seven-barrel glass microelectrodes were directed stereotaxically
(Paxinos and Watson, 1998) to the GP (7.2–8.2 mm anterior to the
interaural line, 2.6–3.6 mm lateral to the midline, 5–7 mm ventral to
the cortical surface). The center recording barrel (1.1–2.0 MΩ) was
ﬁlled with 2 MNaCl with 1% Fast Green (Sigma). The side barrels were
ﬁlled with a 2 M NaCl solution (for automatic current balancing),
SNOG (15 mM, pH 4.5), L-NAME (50 mM, pH 6.5) L-glutamic acid
monosodium salt (GLU; 100 mM, pH 8), respectively. Retaining
currents of 8–10 nAwere applied to drug barrels (20–70 MΩ, positive
for GLU, negative for the other solutions) (Neurophore BH-2 System,
Harvard Apparatus, Holliston, MS, U.S.A.). At the beginning of each
track (0.5 mm ventral to the cortical surface), maximal ejection
currents were applied to each of the drug-containing barrel for
30 min, to concentrate the drug at the pipette tip.
Electrical signals were ampliﬁed and ﬁltered (300 Hz–1.5 kHz
band pass) through a Grass (West Warwick, RI, U.S.A.) AC ampliﬁer
(mod. P511) and audio monitored. The raw activity signal was video
monitored through a Tektronix (Beaverton, OR, U.S.A.) oscilloscope
(mod. 5113). It was then isolated through a World Precision
Instruments (Sarasota, FL, U.S.A.) window discriminator (mod. 121).
The resulting Transistor–Transistor Logic pulses were used to trigger a
Tektronix digitizing oscilloscope (model TDS 430A) for displaying and
printing selected full waveforms of discriminated impulses, in order
to continuously check the absence of variation of impulsemorphology
caused by other active neurons or local tissue movement. The raw
activity signal was also digitally converted and then passed through a
software window discriminator. Subsequently, raw activity digital
signals together with isolated waveforms (4 ms duration for each
extracted event) were displayed on-line by means of a computer
monitor. Waveforms were then stored on a computer together with
their temporal markers (time precision 100 μs), for off-line analysis. A
ratemeter histogram of neuronal activity was continuously displayed
and updated each 5 s on the computer screen together with a counter
window, to detect variations of neuronal ﬁring rate on-line. All
computer operations were performed using the SciWorks package,
version 5.0 (Datawave Technologies, Berthoud, CO, U.S.A.). The
electrode was advanced using a manual hydraulic 10 microdrive
(Narishige, Tokyo, Japan) until the spikes generated by a neuron werewell isolated (signal to noise ratio of 3:1 or greater). Units were not
added to the database if there were marked changes in amplitude or
conﬁguration of the spike or if there was early death of the cell in the
course of recording. Baseline activity of each neuron was recorded for
10 min or more before acute vehicle or drug administration.
Pharmacological treatment
GLUand L-NAMEwere purchased fromSigma; SNOGwas purchased
from Tocris (TOCRIS Bioscience, Northpoint, UK). To exclude direct
effects of the pHof drug solutions on neuronal activity, preliminary tests
were performed in control rats by passing currents of the same intensity
and polarity as that of ejection of drugs through barrels containing
buffered-saline solutions, with pH and concentrations identical to drug
solutions. No effects were observed. Before each test, electrical
resistance of the barrels containing the drug solutions was veriﬁed in
order toexclude the cloggingof oneormorebarrels and to assure proper
drug delivery. Ejection duration and inter-ejection intervals were
controlled by automatic timing equipment.
For each responding neuron, GLU ejection current (40–80 nA, 30 s
ejection time, 90 s inter-ejection interval time) was adjusted in order
to obtain, if possible, a statistically signiﬁcant increase (preferably
about 50% versus basal) in neuronal spike frequency. Continuous
iontophoretic application of L-NAME or SNOG was used to study the
inﬂuence of local NO levels on themagnitude of neuronal responses to
pulsed GLU. Nearly all neurons excited by GLU ejection underwent the
iontophoretic administration of SNOG, 80 nA for 2 min. Some neurons
were tested with SNOG at 40, 80 and 100 nA ejection currents, in
order to explore a possible current dependency of the modulation on
GLU-induced responses. During SNOG continuous administration,
pulsed GLU ejection (at the same current used before SNOG) was
performed. After the end of SNOG ejection, if experimental conditions
allowed it, new control GLU pulses were performed before and during
L-NAME continuous ejection (5 min, 80 nA). SNOG and L-NAME
ejection currents were selected on the basis of current–response
curves previously obtained by our group (Sardo et al., 2002a,b). After
the iontophoresis of a NO-active drug was terminated, recording
continued until both the spontaneous ﬁring rate and the evoked
response to GLU application recovered to baseline. Only cells exhibiting
recovery were included in subsequent analyses.
Histology
At the end of each experiment, the recording site was marked with
Fast Green through the electrode, by using a 50 μA ejection current for
15 min. Subsequently, animals were sacriﬁced with an overdose of
pentobarbital and then transcardially perfused with saline, followed
by 10% buffered formalin. Brains were removed and coronal frozen
sections were cut at 50 μm and stained with cresyl violet for
histological veriﬁcation and reconstruction of recording sites
(Fig. 1). Images of sections were acquired using a Leica DFC Camera
attached to a stereomicroscope (Leica Microsystems Imaging solu-
tions Ltd, Cambridge, UK).
Data analysis
Off-line analyses of spike waveform parameters, neuronal ﬁring
rate and discharge pattern before, during and after drug administra-
tion were performed for each unit. Individual ratemeter histograms
(5 s bin width) were analyzed by means of a non parametric Mann–
Whitney U-test to detect any statistically signiﬁcant treatment-
related change in neuronal ﬁring. To analyze L-NAME- and SNOG-
induced effects, neurons were considered responsive if changes were
signiﬁcant (probability level Pb0.05) for at least six consecutive bins,
the ﬁrst of which was labeled as the onset of a response. For each
neuron, in order to analyze the effects produced by each application of
1 mm
Fig. 1. Histological coronal section 8 mm anterior to the interaural line (photomicrograph, 10×; Nissl–Cresyl Violet staining). The spot inside the dotted circle in the magniﬁcation
(16×) inlet shows a recording site in the globus pallidus.
Table 1
Spontaneous activity of GP units: electrophysiological features of neuronal discharge
patterns and waveforms.
Neuronal
ﬁring
pattern
n Mean ﬁring
rate (Hz)
Mode of
interspike
intervals
(ms)
Mean
interspike
interval
(ms)
Mean
spike
duration
(ms)
Mean peak
to peak
amplitude
(mV)
Regular 39 28.42±12.67 27.16±13.41 37.12±14.15 1.80±0.35 1.21±0.45
Irregular 29 11.22±8.37 59.63±38.22 84.37±22.66 1.78±0.51 1.15±0.36
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to compare the ﬁring rate during drug administration (6 bins) with
the baseline activity calculated during a control period of 60 s (12
bins) before treatment. Inter-spike interval histograms (ISIHs) were
calculated for each unit to analyze the discharge pattern either in
basal conditions or during and after iontophoretic pharmacological
treatment. The basal discharge pattern was evaluated for 5 min. ISIH
analysis was performed using a 1 ms bin width, and the modes of
intervals, mean intervals, standard deviations (SD) of the mean
intervals and coefﬁcients of variation (CV=SD/mean interval) of
intervals were calculated.
Repeated measures analysis of variance (ANOVA) was used to
compare GLU-induced response magnitudes obtained in basal
conditions versus the ones observed during administration of NO-
active drugs. Comparisons between frequencies were performed by
means of a χ2 test. For all statistical tests used, the null hypothesis was
rejected at a P lower than 0.05. If not otherwise indicated, all results
are expressed as means±SD.
Results
Recorded cells within the GP
The bioelectric activity of 68 histologically veriﬁed spontaneously
active GP neurons was recorded. As already found in previous
research (Sardo et al, 2002a), ﬁrst order ISIH analysis allowed us to
discriminate between two different neuronal ﬁring patterns: 39
neurons (57.35%) showed a regular ﬁring with a symmetric unimodal
peak in the ISIH, whereas 29 (42.65%) showed an irregular ﬁring with
no unimodal peak. All recorded impulses had biphasic negative-
positive waveform (Table 1). The comparison between the waveform
parameters of regularly versus irregularly discharging neurons did not
show statistically signiﬁcant difference. A χ2 analysis revealed that
none of the above-reported characteristics of action potentials or
discharge patterns inﬂuenced signiﬁcantly the neuronal responsive-
ness to the application of any drug (Table 2).
Effect of GLU pulsed administration on GP neurons
All neurons were tested with two pulses of GLU (ejection current
ranging from 40 to 80 nA, as described in the Material and methodssection) separated by a 90 s inter-pulse interval, in order to exclude
that the effect of the ﬁrst pulse could inﬂuence the following one;
only the neurons responding to both pulses were considered
responsive to treatment. Among tested neurons, 57 cells displayed
a signiﬁcant increase of their discharge rate during GLU ejection
(mean magnitude +41.90±27.16 %), whereas 11 did not show
signiﬁcant responses. All responding cells were tested with at least
one NO-active drug, as described in the following paragraphs.Effect of GLU and SNOG iontophoretic co-administration on GP neurons
Fifty-two GP neurons were also tested with the iontophoretic
application of SNOG (80 nA for 2 min), which induced statistically
signiﬁcant changes in the ﬁring rate of 43 neurons. In particular, 39 cells
were excited during SNOG ejection (+49.79±28.07%), whereas 4
neurons were inhibited (−41.24±19.23%) and 9 cells did not modify
their discharge. No changes in morphology of ISIHs were observed
during drug administration. The ﬁring rate of responsive cells returned
to the control level immediately after the end of the drug ejection.
Excitatory, inhibitory or null responses were not differently distributed
between regularly and irregularly discharging neurons (Table 2).
Moreover, the spontaneousdischargepatternof nonresponsive neurons
was not modiﬁed during SNOG administration. Furthermore, no spatial
segregation of either responding or not responding cellswas evidenced.
During SNOG ejection, if the neuronal discharge was stable for at
least 1 min, pulsed GLU ejection was performed at the same current
used before. Statistically signiﬁcant modiﬁcations of GLU-evoked
responses were observed during SNOG continuous ejection (Table 2).
In particular, a large incidence of increased GLU-induced responses
magnitude was observed among the neurons previously excited by
Table 2
SNOG effects on GP units: relationships between neuronal drug-responsiveness and
basal ﬁring.
SNOG
effect on
basal ﬁring
n n
rega
n
irregb
χ2 test
(DF=2)
SNOG
effect
on GLU
response
magnitude
n n
rega
n
irregb
χ2 test
(DF=2)
Increase 39 21 18 χ2 1.040 + 34 19 15 χ2 0.627
− 5 2 3
= 0 0 0
Decrease 4 3 1 + 1 1 0
− 0 0 0
= 3 2 1
None 9 4 5 P 0.59 + 4 1 3 P 0.731
− 0 0 0
= 5 3 2
Tot 52 28 24 Tot + 39 21 18
Tot − 5 2 3
Tot = 8 5 3
a Regularly discharging neurons.
b Irregularly discharging neurons.
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Fig. 2. SNOG–GLU interaction. A: Representative rate-meter histogram (bin width 5 s)
showing increased magnitude of GLU-evoked responses during continuous ejection of
SNOG. B: Bar histogram showing mean (±SD) percent magnitude of GLU-evoked
responses before (white column) and during (ruled column) SNOG administration
(*statistically signiﬁcant at Pb0.05).
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Fig. 3. SNOG–GLU interaction. Each point of the ﬁgure plots, for each neuron, the
magnitude of the GLU-induced response during SNOG ejection (80 nA) against the
magnitude of the response to GLU before SNOG administration. The dotted line
separates the area of increased response magnitude from the one of decreased
magnitude. Boxes: cells excited by SNOG alone (white: increased magnitude; black:
decreased magnitude). Circles: cells indifferent to SNOG alone. Triangle: cell inhibited
by SNOG alone. Only the cells displaying SNOG-induced modulation of GLU-induced
responses are represented.
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F=11.231, P=0.002; Fig. 2). Increase or reduction of GLU-induced
response magnitude during SNOG ejection was not dependent on the
magnitude of the control response to GLU (Fig. 3). Interestingly, even
among the 9 cells not directly excited by SNOG ejection, modulation of
GLU-induced responsesmagnitudewas observed in 4 neurons showing
statistically signiﬁcant increase (85.43±61.42 % vs 58.11±50.82%,
F=11.684 , P=0.0419), whereas 5 exhibited responses not signiﬁ-
cantly modulated (Table 2).
Seventeen neurons responding to SNOG ejection at 80 nA were
also tested with SNOG at 40 and 100 nA currents, in order to explore
for a possible current dependency of the SNOG induced modulation
of GLU excitation. Repeated measurement of ANOVA (F=5.39, P=
0.0028) showed signiﬁcant increase of the mean response magni-
tude obtained at both 80 nA (D%=42.46, P=0.0323) and 100 nA
(D%=73.39, P=0.0004) ejection currents versus values obtained
before SNOG (Fig. 4). Furthermore, the GLU-induced responses
observed during SNOG 100 nA ejection were signiﬁcantly greater
than those obtained with SNOG 40 nA ejection currents (D%=54.19,
P=0.0071).
Effect of GLU and L-NAME iontophoretic co-administration on GP
neurons
Fourteen out of the GP neurons excited by pulsed GLU ejection also
received the iontophoretic application of L-NAME at 80 nA for 5 min.
Nine among these cells had been already tested with SNOG and GLU
co-administration (see next paragraph for details). The discharge
activity of 10 cells was signiﬁcantly reduced by drug application
(−34.67±20.41%), whereas the ﬁring of 4 cells was unaffected. The
discharge frequency of responsive cells returned to control level after
the end of drug ejection. No changes in morphology of ISIHs were
observed during current administration. Inhibitory or null responses
were not differently distributed between regularly and irregularly
discharging neurons. Furthermore, the spontaneous discharge pattern
of nonresponsive neurons was not modiﬁed by L-NAME administra-
tion. Finally, no spatial segregation of either responding or not re-
sponding cells was evidenced.
In all neurons pulsed GLU was iontophoretically co-administered
when the effect of L-NAME on the neuronal ﬁring rate was stable for at
least 1 min. All tested neurons showed L-NAME-induced modiﬁcation
of responses to GLU administration; in particular, the 10 cells
inhibited by L-NAME showed either a complete abolition (n=3) or
a statistically signiﬁcant reduction of the magnitude of GLU-induced
responses (36.49±25.23% vs 63.08±53.40%, F=5.512, P=0.0468;Fig. 5). Albeit observable (−52.56%), the reduction in magnitudes did
not reach statistical signiﬁcance in the 4 neurons previously
unaffected by L-NAME ejection (F=4.638, P=0.0976).
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Fig. 5. L-NAME–GLU interaction. A: Representative rate-meter histogram (bin width
5 s) showing decreased magnitude of GLU-evoked responses during continuous
ejection of L-NAME. B: Bar histogram showing mean (±SD) percent magnitude of
GLU-evoked responses before (white column) and during (ruled column) L-NAME
administration (*statistically signiﬁcant at Pb0.05).
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co-administrations
Nine neurons were treated with both co-administration protocols.
With the exception of one neuron excited by SNOG and inhibited by
L-NAME ejection, the cells responding to SNOG (n=5) with an overt
change in basal activity did not display responses to L-NAME
administration, and vice-versa. One neuron did not respond to any
drug. Interestingly, even if no overt changes in basal activity were
observed during the administration of a NO-active drug, all neurons
displayed changes in magnitudes of GLU-induced responses during
both treatments. In fact, all neurons but one exhibited increased
magnitude of responses to GLU ejection during SNOG administration
(76.13±46.56% vs 52.65±39.95%, F=13.756, P=0.0076) and
reduced magnitudes during L-NAME treatment (43.54±27.20 vs
79.16±22.72%, F=6.454, P=0.0386).
Discussion
NO is a versatile gaseous molecule, able to modulate both the
neuronal excitability and the release of neurotransmitters in many
structures of the CNS of mammalians (Cudeiro et al., 1997; Shaw and
Salt, 1997; Ferraro et al., 1999; Trabace and Kendrick, 2000; Prast and
Philippu, 2001; Ahern et al., 2002; Li et al., 2004; Garthwaite, 2008).
Clear NO-mediated actions have been shown in the BG (Cox and
Johnson, 1998; Calabresi et al., 1999; Centonze et al., 2001): in this
regard, strong modulatory effects exerted by NO-active drugs on the
bioelectric activity of striatal, pallidal, subthalamic and nigral
cells have been recently demonstrated (Sardo et al., 2002a,b, 2003,
2006a,b; Carletti et al., 2009), as well as a marked inﬂuence of NO-
active drugs on GABA- and GLU-evoked responses in the STN (Sardo
et al., 2009).
NO-dependent modulation of neuronal responses to GLU
This study, showing modulation of GLU-induced responses of GP
neurons through the manipulation of the nitrergic metabolic system,
extends our previous observation that the NOS inhibitor L-NAME
reduces the discharge activity and, conversely, that NO donor
molecules increase the ﬁring rate of GP cells (Sardo et al, 2002a).
New information was obtained by iontophoretically co-administering
NO-active drugs with GLU: in fact, the administration of L-NAME
signiﬁcantly damped the glutamate-driven excitatory effect down,
while the ejection of SNOG signiﬁcantly intensiﬁed it. The analysis ofthemagnitude of GLU-induced responses during the administration of
SNOG at different currents in the same neurons showed a clear
current dependency of the excitatory modulation induced by the NO
donor. Furthermore, a very few number of cells displaying a reduction
of the magnitude of GLU-dependent responses during SNOG admin-
istration was observed, but no evident relationship was showed
between the sign of the SNOG-induced modulation and the
magnitude of responses to GLU before SNOG administration.
Interestingly, the modulation induced by NO-active drugs on the
magnitude of GLU-induced neuronal responses was not necessarily
linked to a direct, overt effect of the NO donor or the nNOS inhibitor
on the spontaneous neuronal discharge activity. All recorded cells
were characterized by spontaneous activity and probably they
functionally represent projection neurons (Nambu and Llinas, 1997;
Cooper and Stanford, 2000). Despite the different neuronal ﬁring
patterns (regularly and irregularly discharging units), already showed
by previous studies (Ni et al., 2000; Sardo et al, 2002a), no pattern-
related heterogeneous responses to pharmacological treatments were
observed.
Possible mechanisms involved in the NO-dependent modulation of
responses to GLU
The data suggest that the previously observed NO-induced
modulation of the bioelectric activity of GP cells could be obtained,
to some extent, by inﬂuencing the glutamatergic neurotransmission.
Evidences of a ﬁne control exerted by other transmitters or neuro-
modulators on the glutamatergic transmission have already been
highlighted in the GP: e.g., dopamine was suggested to have a role in
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receptors (Hernandez et al., 2006, 2007); further on, the peptidergic
neuromodulator neurotensin selectively enhances GLU transmission
in the GP (Chen et al., 2006). On the other side, several studies showed
a modulatory role of NO on both the neuronal excitability and the
release of GLU (Ohkuma and Katsura, 2001; Prast and Philippu, 2001).
Our present results suggest the NO as a further modulator of GLU
transmission in the GP.
Although NO mainly acts through the activation of the soluble
form of guanylyl cyclase (sGC), which, in turn, produces the second-
messenger cyclic guanosine monophosphate (cGMP), modulated by
cGMP-regulated phosphodiesterases and downstream acting on
cGMP-dependent protein kinases (PKG) or cyclic nucleotide-gated
(CNG) ion channels (Kleppisch and Feil, 2009), the evidenced NO-
induced modulation could also be potentially exerted through
different mechanisms. Although this speciﬁc issue remains to be
experimentally tested, our previous data obtained in both the STN and
the striatum, as well as some considerations on the distribution of
drug-induced effects among neurons, lead us to hypothesize a role for
cGMP in some of the observed effects. Moreover, it must be noted that,
with some sparse exception, no co-localization of nNOS and sGC has
been observed in the same neurons (De Vente et al., 1998). From this
point of view, taking into consideration the NO/cGMP pathway, a
locally applied NO donor (e.g. SNOG) could be potentially able to
modulate the activity of a cell at least containing the sGC, whereas an
iontophoretically administered NOS inhibitor, in this case L-NAME,
necessarily could only inﬂuence the activity of the few neurons
containing both the nNOS and the sGC. This consideration leads to
forecast higher numbers of neurons responding to locally applied NO
donors than to nNOS inhibitors, if only the cGMP pathway is the one
involved in the observed effects. In fact, our previous studies,
exploring changes in spontaneous neuronal discharge induced by
iontophoretically administered NO donors and nNOS inhibitors,
always showed much more responses to NO donors than to nNOS
inhibitors, as well as only sporadically occurring responses of the
same cell to both kinds of molecules. It must be noted that, even in the
present study, when neurons were tested with both NO-active drugs
at different times, the great majority of cells responded with a change
in basal discharge to only one treatment. However, additional
considerations have to be made in order to explain the observed
modulation of GLU-induced responses. In fact, it must be considered
that, although the overt excitatory (to SNOG) or inhibitory (to L-
NAME) responses to NO-active drugs always remained separated in
all neurons treated with both drugs, at the same time all of these cells
showed clear, statistically signiﬁcant modulation exerted by both NO-
active drugs on the neuronal responses to GLU ejection, suggesting
the possible involvement of others effectors than sGC. Thus, the
observed effects could be the result of cGMP-independent pathways
such as direct protein nitrosylation by NO or peroxynitrite formation
and subsequent protein nitration and oxidation (Ahern et al., 2002;
Yoshida et al., 2006; Zhou et al., 2008). Moreover, it must be observed
that, even if a direct effect of the NO-active drug was not evident on
the basal neuronal discharge, often (always, in the neurons tested
with both drugs) a signiﬁcant effect was observed on the magnitude
of GLU-induced responses. With this perspective, it is noteworthy the
close relationship between the NMDA receptor (NMDAR) and the
NOS, as well as their possible downstream feedback interactions; for
example, S-nitrosylation of NMDAR was proposed as a modulating
mechanism to escape from receptor overactivation (Choi et al., 2000).
Furthermore, a sGC-PKG dependent control exerted by NO on the
function of the AMPA receptor (AMPAR) has been suggested
(McMahon and Ponomareva, 1996). Moreover, recent studies hy-
pothesize the involvement of NO in long term potentiation (LTP)
depending on metabotropic GLU receptors (mGluR) (Anwyl, 2009).
All three types of GLU receptors are expressed in GP (Kaneda et al.,
2007) so representing potential targets for nitrergic action.Furthermore, an indirect involvement of GABAergic transmission
cannot be ruled out in the interpretation of our data; in fact, the
possible interaction between NO and GABA receptors must be taken
into consideration, as suggested by some evidence about the
depression induced by both cGMP and NO donors on GABA-
receptor-mediated responses (Wexler et al., 1998); in this regard,
we previously observed NO-mediated modulation of GABA neuro-
transmission in STN, in agreement with the idea that nitrergic
intervention could represent a negative modulator in GABAergic
synapses (Sardo et al., 2009).
Finally, it has been shown that NO can increase cerebral blood ﬂow
(Prado et al., 1992) by releasing vascular smooth muscle cells
(Moncada et al., 1991). Therefore, the microiontophoretic application
of SNOG or L-NAME could inﬂuence the microvascular tone by
interfering with NO formation. However, it seems unlikely that the
effects of these compounds on GP neuronal activity might be
secondary to modiﬁcations in local microcirculation, inasmuch as
recent data show that the microiontophoretic application of different
NO-modulating compounds in the visual cortex do not modify the
cortical blood ﬂow measured with laser-Doppler ﬂow meter (Kara
and Friedlander, 1999). Moreover, our hypothesis that the effect of
NO-acting drugs on GP neuronal activity is primarily attributable to a
direct effect on neuronal targets is corroborated by the ﬁnding that
topical application of L-arginine, the endogenous substrate of the
synthesis of NO, induces only a slight dilatation of pial arterioles in
normotensive rats (Riedel et al., 1995).
Implication for GP function in BG circuits
Then, the observed NO-induced modulation of the intensity of
excitatory responses to GLU could be due either to a reinforcement of
GLU transmission or to an interference with GABA receptors function.
In fact, intrinsic NO-producing interneurons exist in the GP, which
could have a role in modulating output cells' activity; the synaptic
terminals of these NO-producing neurons are anatomically close to
both striatal GABAergic and subthalamic glutamatergic endings
(Bolan et al., 2000). Thus, the suggested NO-mediated control could
represent a mechanism able to regulate the ﬂow of glutamatergic
inputs to the GP arising from several CNS regions; out of these, the
STN, through its reciprocal connections with GP, constitutes a
structure of primary importance. According to the standard models
of BG processing, GP and STN are involved together in the indirect
pathway (Smith et al, 1998); they form a key network, characterized
by pacemaker activity and a powerful impact on the BG output (Plenz
and Kitai, 1999; Bevan et al., 2002). The GP gives rise to massive
topographically organized GABAergic projections that terminate
throughout the entire extent of the STN; in turn, glutamatergic STN
neurons project back to GP playing crucial roles in both the
maintenance of the ﬁring activity and the generation of ﬁring patterns
(Kita et al., 2004). Moreover, STN relays to GP the activity driven by
inputs directly arising frommotor-related areas of the cerebral cortex
(Nambu et al., 2000). A functional interaction between the nitrergic,
GABAergic and glutamatergic neurotransmitter systems has been
recently shown in the STN, suggesting a modulatory role exerted by
NO availability on the GABA- and GLU-dependent changes of STN
neuron discharge activity (Sardo et al., 2009). Furthermore, our
present data show qualitatively similar effects of NO-active drugs on
the GLU-evoked responses in the GP. In this framework, NO could play
a modulatory role on both the GP neuronal activity and the reciprocal
interactions of GP/STN network, in either normal conditions or
pathophysiological states. In this regard, it is interesting to mention
that an increase of NOS mRNA expression in the GP was observed in
patients with Parkinson's disease (PD; Eve et al., 1998). Altered local
level of NO could have effect on both the basal neuronal activity and
the modulation of classical neurotransmission, leading to abnormal
activity patterns in GPe neurons, such as bursty or synchronous
1119P. Sardo et al. / Life Sciences 88 (2011) 1113–1120rhythmic activity, which are thought to have far-reaching conse-
quences for BG function and motor control (Bolam et al., 2000);
moreover, altered synchronized and oscillatory activity of the GP/STN
network, a central pacemaker likely responsible for synchronized
oscillatory activity in the normal and pathological BG (Plenz and Kitai,
1999), could result in a less efﬁcient coding of information by BG and,
in turn, could contribute to the symptoms of Parkinson's disease
(Gatev et al., 2006).
Conclusions
The magnitude of glutamate-induced excitatory effects was signif-
icantly decreased by L-NAME, whereas it was increased by SNOG. Our
results raise the idea that NO cerebral levels could represent a tool to
modulate the glutamatergic neurotransmission in the GP, so affecting
the BG output either in normal or pathological conditions. In particular,
the suggested NO-mediated control could have a pivotal role in the
regulation of the relationship between GP/STN, by acting on both their
reciprocal inhibitory/excitatory connections.
Conﬂict of interest statement
No competing interests.
References
Ahern GP, Klyachko VA, Jackson MB. cGMP and S-nitrosylation: two routes for
modulation of neuronal excitability by NO. Trends Neurosci 2002;25(10):510–7.
Anwyl R. Metabotropic glutamate receptor-dependent long-term potentiation. Neuro-
pharmacology 2009;56(4):735–40.
BevanMD, Magill PJ, Terman D, Bolam JP, Wilson CJ. Move to the rhythm: oscillations in
the subthalamic nucleus–external globus pallidus network. Trends Neurosci
2002;25(10):525–31.
Bolam JP, Hanley JJ, Booth PA, BevanMD. Synaptic organisation of the basal ganglia. J Anat
2000;196(4):527–42.
Bolan EA, Gracy KN, Chan J, Triﬁletti RR, Pickel VM. Ultrastructural localization of
nitrityrosine within the caudate–putamen nucleus and the globus pallidus of
normal rat brain. J Neurosci 2000;20:4798–808.
Calabresi P, Gubellini P, Centonze D, Sancesario G,MorelloM, GiorgiM, et al. A critical role
of the nitric oxide/cGMP pathway in corticostriatal long-term depression. J Neurosci
1999;19(7):2489–99.
Carletti F, Ferraro G, Rizzo V, D'Agostino S, Lonobile G, Sardo P. Nitric oxide- and cGMP-
active compounds affect the discharge of substantia nigra pars reticulata neurons:
in vivo evidences in the rat. J Neural Transm 2009;116(5):539–49.
Centonze D, Pisani A, Bonsi P, Giacomini P, Bernardi G, Calabresi P. Stimulation of nitric
oxide–cGMP pathway excites striatal cholinergic interneurons via protein kinase G
activation. J Neurosci 2001;21(4):1393–400.
Chen L, Yung KK, Yung WH. Neurotensin selectively facilitates glutamatergic
transmission in globus pallidus. Neuroscience 2006;141(4):1871–8.
Chen L, Yung KK, Chan YS, Yung WH. 5-HT excites globus pallidus neurons by multiple
receptor mechanisms. Neuroscience 2008;151(2):439–51.
Choi YB, Tenneti L, Le DA, Ortiz J, Bai G, Chen HS, et al. Molecular basis of NMDA
receptor-coupled ion channel modulation by S-nitrosylation. Nat Neurosci 2000;3
(1):15–21.
Conn PJ, Battaglia G, Marino MJ, Nicoletti F. Metabotropic glutamate receptors in the
basal ganglia motor circuit. Nat Rev Neurosci 2005;6(10):787–98.
Cooper AJ, Stanford IM. Electrophysiological and morphological characteristics of three
subtypes of rat globus pallidus neurone in vitro. J Physiol 2000;527(2):291–304.
Cox BA, Johnson SW. Nitric oxide facilitates N-methyl-D-aspartate-induced burst ﬁring
in dopamine neurons from rat midbrain slices. Neurosci Lett 1998;255(3):131–4.
Cudeiro J, Rivadulla C, Rodríguez R, Grieve KL, Martínez-Conde S, Acuña C. Actions of
compounds manipulating the nitric oxide system in the cat primary visual
cortex. J Physiol 1997;504(2):467–78.
De Vente J, Hopkins DA, Markerink-Van IttersumM, Emson PC, Schmidt HH, Steinbusch
HW. Distribution of nitric oxide synthase and nitric oxide-receptive, cyclic GMP-
producing structures in the rat brain. Neuroscience 1998;87(1):207–41.
Eve DJ, Nisbet AP, Kingsbury AE, Hewson EL, Daniel SE, Lees AJ, et al. Basal ganglia
neuronal nitric oxide synthase mRNA expression in Parkinson's disease. Brain Res
Mol Brain Res 1998;63(1):62–71.
Ferraro G, Montalbano ME, La Grutta V. Nitric oxide and glutamate interaction in the
control of cortical and hippocampal excitability. Epilepsia 1999;40(7):830–6.
Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci
2008;27(11):2783–802.
Gatev P, Darbin O, Wichmann T. Oscillations in the basal ganglia under normal
conditions and in movement disorders. Mov Disord 2006;21(10):1566–77.
Hazrati LN, Parent A. Convergence of subthalamic and striatal efferents at pallidal level
in primates: an anterograde double-labeling study with biocytin and PHA-L. Brain
Res 1992;569(2):336–40.Hernandez A, Ibañez-Sandoval O, Sierra A, Valdiosera R, Tapia D, Anaya V, et al. Control
of the subthalamic innervation of the rat globus pallidus by D2/3 and D4 dopamine
receptors. J Neurophysiol 2006;96(6):2877–88.
Hernandez A, Sierra A, Valdiosera R, Floran B, Erlij D, Aceves J. Presynaptic D1 dopamine
receptors facilitate glutamatergic neurotransmission in the rat globus pallidus.
Neurosci Lett 2007;425(3):188–91.
Kaneda K, Kita T, Kita H. Repetitive activation of glutamatergic inputs evokes a long-
lasting excitation in rat globus pallidus neurons in vitro. J Neurophysiol 2007;97
(1):121–33.
Kara P, Friedlander MJ. Arginine analogs modify signal detection by neurons in the
visual cortex. J Neurosci 1999;19:5528–48.
Kita H, Nambu A, Kaneda K, Tachibana Y, Takada M. Role of ionotropic glutamatergic
and GABAergic inputs on the ﬁring activity of neurons in the external pallidum in
awake monkeys. J Neurophysiol 2004;92(5):3069–84.
Kleppisch T, Feil R. cGMP signalling in the mammalian brain: role in synaptic plasticity
and behaviour. Handb Exp Pharmacol 2009;191:549–79.
Lee CR, Tepper JM. Basal ganglia control of substantia nigra dopaminergic neurons. J Neural
Transm 2009;73:71–90.
Li DP, Chen SR, Finnegan TF, Pan HL. Signalling pathway of nitric oxide in synaptic GABA
release in the rat paraventricular nucleus. J Physiol 2004;554(1):100–10.
McMahon DG, Ponomareva LV. Nitric oxide and cGMP modulate retinal glutamate
receptors. J Neurophysiol 1996;76(4):2307–15.
Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and
pharmacology. Pharmacol Rev 1991;43:109–42.
Mouroux M, Hassani OK, Feger J. Electrophysiological and Fos immunohistochemical
evidence for the excitatory nature of the parafascicular projection to the globus
pallidus. Neuroscience 1997;81(2):387–97.
Naito A, Kita H. The cortico-pallidal projection in the rat: an anterograde tracing study
with biotinylated dextran amine. Brain Res 1994;653(1–2):251–7.
Nambu A, Llinas R. Morphology of globus pallidus neurons: its correlation with
electrophysiology in guinea pig brain slices. J Comp Neurol 1997;377(1):85–94.
Nambu A, Tokuno H, Hamada I, Kita H, Imanishi M, Akazawa T, et al. Excitatory cortical
inputs to pallidal neurons via the subthalamic nucleus in the monkey. J Neurophysiol
2000;84(1):289–300.
Ni Z, Bouali-Benazzouz R, Gao D, Benabid A, Benazzouz A. Changes in the ﬁring pattern
of globus pallidus neurons after the degeneration of nigrostriatal pathway are
mediated by the subthalamic nucleus in the rat. Eur J Neurosci 2000;12(12):
4338–44.
Ohkuma S, Katsura M. Nitric oxide and peroxynitrite as factors to stimulate
neurotransmitter release in the CNS. Prog Neurobiol 2001;64(1):97-108.
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of
subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res
Brain Res Rev 1995;20(1):128–54.
Parent A, Sato F, Wu Y, Gauthier J, Levesque M, Parent M. Organization of the basal
ganglia: the importance of axonal collateralization. Trends Neurosci 2000;23(10):
S20–7.
Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic
Press; 1998.
Plenz D, Kitai ST. A basal ganglia pacemaker formed by the subthalamic nucleus and
external globus pallidus. Nature 1999;400(6745):677–82.
Prado R, Watson BD, Kuluz J, Dietrich WD. Endothelium derived nitric oxide synthase
inhibition. Effects on cerebral blood ﬂow, pial artery diameter, and vascular
morphology in rats. Stroke 1992;23:1118–23.
Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol
2001;64(1):51–68.
Riedel MW, Anneser F, Haberl RL. Different mechanisms of L-arginine induced dilation of
brain arterioles in normotensive and hypertensive rats. Brain Res 1995;671:21–6.
Rodrigo J, Springall DR, Uttenthal O, Bentura ML, Abadia-Molina F, Riveros-Moreno V,
et al. Localization of nitric oxide synthase in the adult rat brain. Phil Trans Roy Soc
Lond B Biol Sci 1994;345(1312):175–221.
Rouse ST, Marino MJ, Bradley SR, Awad H, Wittmann M, Conn PJ. Distribution and roles
of metabotropic glutamate receptors in the basal ganglia motor circuit: implica-
tions for treatment of Parkinson's disease and related disorders. Pharmacol Ther
2000;88(3):427–35.
Sardo P, Ferraro G, Di Giovanni G, Galati S, La Grutta V. Inﬂuence of nitric oxide on the
spontaneousactivity of globuspallidusneurones in the rat. J Neural Transm2002a;109
(11):1373–89.
Sardo P, Ferraro G, Di Giovanni G, Galati S, La Grutta V. Inhibition of nitric oxide
synthase inﬂuences the activity of striatal neurons in the rat. Neurosci Lett
2002b;325(3):179–82.
Sardo P, Ferraro G, Di Giovanni G, La Grutta V. Nitric oxide-induced inhibition on striatal
cells and excitation on globus pallidus neurons: a microiontophoretic study in the
rat. Neurosci Lett 2003;343(2):101–4.
Sardo P, Ferraro G, Carletti F, D'Agostino S, La Grutta V. The discharge of subthalamic
neurons is modulated by inhibiting the nitric oxide synthase in the rat. Neurosci
Lett 2006a;396(3):252–6.
Sardo P, Carletti F, D'Agostino S, Rizzo V, Ferraro G. Effects of nitric oxide-active drugs
on the discharge of subthalamic neurons: microiontophoretic evidence in the rat.
Eur J Neurosci 2006b;24(7):1995–2002.
Sardo P, Carletti F, D'Agostino S, Rizzo V, La Grutta V, Ferraro G. Intensity of GABA-
evoked responses is modiﬁed by nitric oxide-active compounds in the
subthalamic nucleus of the rat: a microiontophoretic study. J Neurosci Res 2009;87
(10):2340–50.
Sato F, Lavallee P, Levesque M, Parent A. Single-axon tracing study of neurons of the
external segment of the globus pallidus in primate. J Comp Neurol 2000;417(1):
17–31.
1120 P. Sardo et al. / Life Sciences 88 (2011) 1113–1120Shaw PJ, Salt TE. Modulation of sensory and excitatory amino acid responses by nitric
oxide donors and glutathione in the ventrobasal thalamus of the rat. Eur J Neurosci
1997;9(7):1507–13.
Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect
pathways of the basal ganglia. Neuroscience 1998;86(2):353–87.
Trabace L, Kendrick KM. Nitric oxide can differentially modulate striatal neurotrans-
mitter concentrations via soluble guanylate cyclase and peroxynitrite formation.
J Neurochem 2000;75(4):1664–74.
Wexler EM, Stanton PK, Nawy S. Nitric oxide depresses GABAA receptor function via
coactivation of cGMP-dependent kinase and phosphodiesterase. J Neurosci
1998;18(7):2342–9.Yasukawa T, Kita T, Xue Y, Kita H. Rat intralaminar thalamic nuclei projections to the
globus pallidus: a biotinylated dextran amine anterograde tracing study. J Comp
Neurol 2004;471(2):153–67.
Yoshida T, Inoue R, Morii T, Takahashi N, Yamamoto S, Hara Y, et al. Nitric oxide
activates TRP channels by cysteine S-nitrosylation. Nat Chem Biol 2006;2(11):
596–607.
Zhou FW, Matta SG, Zhou FM. Constitutively active TRPC3 channels regulate basal
ganglia output neurons. J Neurosci 2008;28(2):473–82.
